Plansee reports a 10% fall in sales in the 2019/2020 fiscal year, from €1.52 billion to €1.38 billion. Despite this, the company said that it continued to invest, with €206 million for equipment and infrastructure, and €68 million for research and development. Rew products accounted for 31% of sales in the past fiscal year, up from 29%. Plansee also recorded increasing demand from the medical technology and the semiconductor industry.
‘In addition to the trade conflict between the USA and China, declining orders from the European automotive and the mechanical engineering industry in particular resulted in the slump in sales in the 2019/2020 fiscal year,’ said Karlheinz Wex, board spokesperson.
Wex added that the group was prepared to cope with the consequences of the coronavirus crisis.
‘We have to expect the business environment to remain difficult this year,’ he said. ‘At the same time, we're convinced that the Plansee Group is competitively positioned and, above all, prepared for crises.’
This story uses material from Plansee, with editorial changes made by Materials Today. The views expressed in this article do not necessarily represent those of Elsevier.
